Clozapine therapy for a patient with a history of Hodgkin's disease.
Miller
P R
PR
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced*; D012074:Remission Induction; D018967:Risperidone / Q000627:therapeutic use; D016896:Treatment Outcome; D014635:Valproic Acid / Q000627:therapeutic use
D014150:Antipsychotic Agents; D014635:Valproic Acid; D003024:Clozapine; D018967:Risperidone